ANIMAL HEALTH NEWS-June

Biogénesis Bagó participated in the 32nd World Buiatrics Congress 2024 in Cancun, Mexico, presenting its portfolio of solutions for animal productivity and sharing perspectives with over 1,500 participants on current and future industry challenges to develop sustainable and effective solutions. Additionally, Biogénesis Bagó has expanded to Europe with new offices in Madrid, consolidating itself as a world leader in animal reproduction by incorporating HIPRA's hormonal products, aiming to reinforce its portfolio, enter new markets, and establish commercial operations in Europe.

?? Biogénesis Bagó participated in the 32nd World Buiatrics Congress 2024 in Cancun, Mexico, from May 20 to 24. The event discussed the latest advances in the bovine industry. As a sponsor of this internationally significant forum, presented its portfolio of solutions for animal productivity. The company, along with more than 1,500 participants, including veterinary professionals and world-renowned experts, shared perspectives on the current and future challenges of the industry, building joint ideas to develop sustainable and effective solutions. (motivar.com.ar, June).

?? Biogénesis Bagó lands in Europe and sets up in Spain. From new offices located in Madrid, the Argentine company is now present in more than 60 countries. In Spain, the company is in the process of establishing itself after the acquisition, in 2022, of HIPRA's line of hormonal products for animal reproduction. In this way, Biogénesis consolidated itself as a world leader in the field of animal reproduction, a sector in which it already had many years of experience. With a focus on providing increasingly better solutions for animal productivity, in 2022 it incorporated HIPRA's animal reproduction line, a company with more than 50 years of experience in the market and with 40 own subsidiaries worldwide. This acquisition will allow Biogénesis Bagó to reinforce its portfolio by adding complementary products, reach 30 new markets, consolidate its presence in the Middle East, North Africa, and Latin America, and begin its commercial operations in Europe. (animalshealth.es, 16th of June).

?? Bimeda, Inc. announced the launch of Bimasone, the first generic flumethasone for certain diseases known to be responsive to anti-inflammatory corticoids in horses, dogs and cats. Bimasone injection is supplied in a 0.5 mg/mL concentration in 100 mL multi-dose vials.?(company press release).

?? MSD Argentina launches an innovation for the control of bovine ticks. It is EXZOLT? 5% Pour-On, from MSD Animal Health, a molecule for the treatment of bovine ticks, horn flies, and other ectoparasites. The company developed this molecule, Fluralaner 50 mg, as an innovation for the control of bovine ticks in Argentina. It is the first molecule for the treatment of infestations caused by ticks, horn flies, and other ectoparasites in more than 30 years. (motivar.com.ar, June).

?? The FDA announced it has approved generic?ZyVet Animal Health, Inc.'s Phenylpropanolamine Hydrochloride chewable tablets for the control of urinary incontinence in dogs.?(FDA).?

?? Trupanion, Inc., the leading provider of medical insurance for cats and dogs in North America, and Boehringer Ingelheim, one of the largest innovators in animal disease prevention and treatment globally, today announced a strategic collaboration to provide pets and their families increased access to high-quality healthcare and enhanced disease treatment and protection. Both companies have strong commitments to caring for pets throughout their lifetime. This collaboration will allow them to leverage their collective expertise and data to derive insights that will enable the early detection of risk factors for common conditions affecting pets. Ultimately, this will support earlier detection and better management of diseases. The two companies will work together on continuing veterinarian and consumer education, product extensions, promotions, peer-reviewed publications, and other efforts in support of pet healthcare. (businesswire.com, June 14th).

?? Bionote USA?has added a new one-step rapid test for the detection of Canine Heartworm (CHW) to its line of in-clinic diagnostic products. The standalone antigen test requires no analyzer or buffer solution, and results are ready in minutes. (company press release).

?? The FDA sent a warning letter to?Safari Stem Cell, stating that the company is marketing unapproved new animal drugs.? FDA Investigators also documented significant deviations from the Current Good Manufacturing Practice (CGMP) regulations for Finished Pharmaceuticals.?(AVMA SmartBrief -?FDA).

?? Ceva Santé Animale is developing new vaccines for bovine respiratory disease with Moredun Research Institute. In 2023, Ceva Santé Animale (Ceva) and Moredun Research Institute (MRI) have been awarded ￡900,000 from the Biotechnology and Biological Sciences Research Council (BBSRC, United Kingdom) to develop new vaccines targeting viruses and bacteria responsible for bovine respiratory disease (BRD). In the current context of emergence of antimicrobial resistance and rational use of antibiotics, prevention of infection by vaccination is of utmost importance. Among cattle diseases that can be prevented by vaccination, bovine respiratory disease (BRD) is a primary target; BRD is highly prevalent, markedly reducing welfare and productivity of both dairy and beef cattle worldwide. Furthermore, current vaccines against major bovine viral and bacterial respiratory pathogens lacks efficacy or convenience or both. (Company Linkedin, June).

?? Ceva Santé Animale Colombia: This week we were pleased to join the XXI edition of FENAVI, the most important poultry congress in Colombia. As the other editions? CEVA was present as one of the main sponsors, welcoming our business partners, customers and colleagues to present our innovative technology on vaccines (Nextmune, Trasmune, Vectormune) automatization solutions and diagnostic services reinforcing our leadership in the poultry health market segment in Colombia. Once an animal health focused company and aligned with our commitment with the animal welfare, we donate part of our marketing investments to a companion animal shelter. Our companion animal team also presented to visitors our products Adaptil, Yoos and Feliway a behave and wellbeing solutions for pets and their tutors. (Company Linkedin, June).

?? Zoetis Argentina goes for more prevention and quality of life for pets. The company reinforces its commitment to education in prevention and promotes its lines of dermatology, antiparasitics, and biologicals. At the latest Intermédica Veterinary Days, it presented a series of key concepts for the growth of veterinary professionals and shared its product offerings for pets. Juliana Stalzer (Technical Manager of Companion Animals) spoke about prevention, with antiparasitic products and the entire line of biologicals, for both dogs and cats, as well as products for chronic treatments. (motivar.com.ar, June).

?? Elanco Animal Health?announced an agreement with?PURETEIN Bioscience?LLC, designating Elanco as the exclusive distributor of PURETEIN’s celluTEIN bioactive livestock protein feed supplement for swine in the US.?(National Hog Farmer).

?? Elanco Spain launches a new podcast channel on animal health and wellness. Elanco's podcast channel 'An Expert, My Pet and I' will offer a new episode each month with information, curiosities, and expert answers to the most interesting questions about pet care and wellness. 'An Expert, My Pet and I', Elanco's new podcast channel on Spotify, reinforces the company's commitment to animal health and wellness, providing pet lovers with direct access to expert knowledge and advice. This initiative is part of the 'My Pet and I Elanco' program, which also includes other social media channels and a digital portal with content designed and developed by experts after analyzing the main concerns of pet owners. The new channel will offer a new episode each month in which an expert will address current and relevant topics in animal health and veterinary care. (animalshealth.es, 14th of June).

?? IDEXX Laboratories?announced the launch of the Catalyst Pancreatic Lipase Test, a single-slide solution for canine and feline patients suspected of pancreatitis.?(company press release).

?? Virbac Spain launches Feluro?, the new oral solution from Virbac for the health of the lower urinary tract in cats. Expanding its range of supplements with the launch of Feluro?, an easy-to-administer solution formulated for one of the common conditions in cats with recurring issues: two-thirds of affected cats experience up to three relapses annually. Therefore, it is crucial to adopt measures that help maintain urinary health, such as promoting water consumption, maintaining bladder mucosa integrity, reducing stress, and keeping urine sterile. Feluro? represents a palatable and easy-to-administer option to support the urinary tract health of cats, with palatability and tolerance studies in cats showing that 92% of cats accept their food mixed with Feluro?. It is a unique blend of natural ingredients: Hibiscus, which helps keep the urinary tract sterile and has antioxidant effects; N-acetyl-D-glucosamine, a component of glycosaminoglycans (GAGs) that coat the urinary tract; and green tea concentrate, rich in L-theanine, which helps cats relax. (diarioveterinario.com, 14th of June).

?? Vetoquinol Spain is introducing a new website dedicated to Felpreva, the antiparasitic specifically designed for cats. The site can be accessed at www.gatossinbichos.es and is also accessible from the Vetoquinol website. Since its launch, the goal of this product has been to simplify feline deworming, reducing stress for the animal, the veterinarian, and the owner. Felpreva? is an antiparasitic that combines broad-spectrum protection with the longest duration for cats. Up to 13 weeks of treatment and prevention against fleas and ticks, combined with treatment against mites, gastrointestinal nematodes, lungworms, and tapeworms. All of this is delivered in a single spot-on application. (diarioveterinario.com, 11th of June).

?? Over Argentina showcased its offering for small animals. The laboratory presented Overdex, a sedative and analgesic that promises to facilitate veterinary practice due to its benefits. For the fourth consecutive year, the national laboratory Over participated in the Intermédica Veterinary Days, exhibiting its entire range of products for small animals and specifically promoting a sedative and analgesic that promises to facilitate veterinary practice. This is Overdex, their latest development and innovation: a dexmedetomidine, which is the active part of medetomidine, with a much more potent effect, a lower dose, and fewer side effects, particularly cardiovascular and respiratory. (motivar.com.ar, June).

?? Vetanco Brasil participated in IPVS in Leipzig, Germany, one of the most important scientific events in swine farming. It involved the exchange of experiences among experts and the presentation by the Brazilian delegation of four scientific papers that were developed with university research centers. Additionally, they had a presence at a stand with Dr. Bata Brazil. (feedfood.com.br, June).

?? Farmabase de Brasil led by Vitor Franceschini (CEO), it is consolidating its global expansion strategy. Today, they have their teams in several countries, with Argentina being their largest market, but with a strong presence in Mexico and Colombia. The company also has subsidiaries in Paraguay and the Caribbean. Additionally, they have a presence in 20 other countries with their products for swine and poultry. (feedfood.com.br, June).

?? Syngene International Limited has recently developed a formula for a leading Animal Healthcare company using a multi-antiparasitic drug combination to treat dogs suffering from ticks, roundworm, hookworm, pinworm, and other worm infections. Their team ensured efficacy, safety, and stability, delivering high-quality clinical batches in record time. Syngene is a contract research, development, and manufacturing organization (CRDMO) that provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal healthcare, consumer goods, and agrochemical companies. (Company Linkedin, June).

Please, contact us if you are interested in our services...????

BERNARDO OTERO Animal Health business leadership in LATIN AMERICA

CEO & Founder de NEXUS ANIMAL HEALTH

Please Subscribe ?? on LinkedIn https://www.dhirubhai.net/build-relation/newsletter-follow?entityUrn=6862344212038328321